We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · May 16, 2023

Nabiximols Oromucosal Spray in Patients With MS-Related Bladder Dysfunction

Multiple Sclerosis and Related Disorders

 

Additional Info

Multiple Sclerosis and Related Disorders
Nabiximols oromucosal spray in patients with multiple sclerosis-related bladder dysfunction: A prospective study
Mult Scler Relat Disord 2023 Apr 09;74(xx)104711, V Torri Clerici, L Brambilla, PL Politi, F Viggiani, S Mercurio, S Tonietti, M Ronzoni, SG Crisafulli, C Antozzi, I Tramacere, C Redemagni, P Confalonieri

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading